Immunic
IMUX
IMUX
65 hedge funds and large institutions have $50.7M invested in Immunic in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
10.34% less ownership
Funds ownership: 55.84% → 45.5% (-10%)
25% less call options, than puts
Call options by funds: $428K | Put options by funds: $570K
Holders
65
Holding in Top 10
1
Calls
$428K
Puts
$570K
Top Buyers
| 1 | +$1.22M | |
| 2 | +$428K | |
| 3 | +$373K | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$265K |
| 5 |
IAM
Innovis Asset Management
Chicago,
Illinois
|
+$265K |
Top Sellers
| 1 | -$5.56M | |
| 2 | -$1.9M | |
| 3 | -$1.17M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.06M |
| 5 |
Millennium Management
New York
|
-$800K |